Comparative Effectiveness of Linvoseltamab Versus Current Real-World (RW) Standard-of-Care (SOC) Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM): Key Subgroups Analysis
Shaji Kumar,Sundar Jagannath, Katja C. Weisel,Laura Rosinol Dachs, Meletios-Athanasios Dimopoulos, David S. Siegel,Jorge Monge,Xavier Leleu,Juan Du,Javier de la Rubia,Jae Hoon Lee,Maria-Victoria Mateos,Borja Puertas Martinez,Alessandro Gozzetti,Dominik Dytfeld,Enrique M. Ocio,Joan Blade,Shuji Ozaki, Meral Beksac, Fernando Escalante, Madhu Nagaraj, Rafla Hassan,Paul Spin, Nicolle Bonar, Mostafa Shokoohi, Muhaimen Siddiqui,Di Wang, Kevin Hou, Jeannette Green, Olivier Humblet,Alexander Breskin,James Harnett,Wenzhen Ge,Rachel E. Sobel,Jessica J. Jalbert,Glenn S. Kroog,Karen Rodriguez Lorenc,Qiufei Ma,Christian Hampp,Brian G. M. Durie BLOOD（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper